Highlights
- Comprehensive phytocannabinoid profile was defined in hemp seeds, sprouts and microgreens.
- Eight varieties and one accession of hemp from different chemotypes were analyzed.
- The main carboxylated and decarboxylated phytocannabinoids were quantified by HPLC-HRMS.
- Enantiomeric composition of CBDA, THCA and CBCA in hemp microgreens was investigated.
Abstract
Hemp-sprouts are emerging as a new class of attractive functional food due to their numerous health benefits when compared to other sprout species. Indeed, the high content of beneficial components including polyphenols and flavonoids makes this type of food a promising and successful market. However, the available literature on this topic is limited and often conflicting as regards to the content of phytocannabinoids. High-performance liquid chromatography coupled to high-resolution mass spectrometry (HPLC-HRMS) was applied in an untargeted metabolomics fashion to extracts of hemp seeds, sprouts and microgreens of nine different genotypes. Both unsupervised and supervised multivariate statistical analysis was performed to reveal variety-specific profiles of phytocannabinoids with surprisingly remarkable levels of phytocannabinoids even in chemotype V samples. Furthermore, a targeted HPLC-HRMS analysis was carried out for the quantitative determination of the major phytocannabinoids including CBDA, CBD, CBGA, CBG, CBCA, CBC, THCA, and trans-Δ9-THC. The last part of the study was focused on the evaluation of the enantiomeric composition of CBCA in hemp seeds, sprouts and microgreens in the different varieties by HPLC-CD (HPLC with online circular dichroism). Chiral analysis of CBCA showed a wide variability of its enantiomeric composition in the different varieties, thus contributing to the understanding of the intriguing stereochemical behavior of this compound in an early growth stage. However, further investigation is needed to determine the genetic factors responsible for the low enantiopurity of this compound.
Introduction
Cannabis sativa L. has emerged in the last decade as a valuable crop for its low environmental impact and as an extraordinary source of food, textiles, plastics, paper, paint, construction material, as well as biofuel and animal feed [1]. Moreover, its ability to produce a peculiar class of bioactive compounds called phytocannabinoids, along with a rich fraction of other antioxidant molecules, has made this plant an interesting material for clinical applications and scientific research. In particular, a large inventory of phytocannabinoids has been reported a few years ago by Hanuš et al. [2], to which other new interesting molecules have been recently added [3], [4], [5], [6], [7], [8]. The phytocannabinoid profile has been extensively investigated in mature inflorescences, as well as in other cannabis derived products, of different cannabis chemovars with an outstanding qualitative and quantitative variability [9], [10], [11], [12], [13], [14]. On the other hand, phytocannabinoids seemed to be absent in early stages of plant growth, particularly in the sprouting process since their biosynthesis is thought to be associated with the presence of the glandular trichomes [15].
In a work by Frassinetti et al., phytocannabinoids could be detected in seeds, probably as a carry-over effect of the surrounding bracts, but not in sprouts [16]. Conversely, other important macronutrients could be determined in hemp sprouts, such as the characteristic flavonoids cannflavins A and B with anti-inflammatory properties [17] potentiated by a balanced amount of ω-3 and ω-6 essential fatty acids [15]. More recently, Pannico et al. compared the chemical profile of hemp microgreens (9 days after sowing) of six hemp cultivars in terms of organic acids, amino acids, and polyphenols and disclosed for the first time the presence of various phytocannabinoids [18]. In particular, the concentration of the non-psychotropic cannabidiolic acid (CBDA) and its decarboxylated counterpart cannabidiol (CBD) reached concentrations above 2000 µg/100 g and 50 µg/100 g respectively, being the most abundant species among all phytocannabinoids detected [18]. Other species found were the narcotic Δ9-tetrahydrocannabinol (Δ9-THC) and its carboxylated non-narcotic precursor tetrahydrocannabinolic acid (THCA) that reached the maximum concentration of 10 µg/100 g and 130 µg/100 g respectively [18]. Lastly, cannabigerolic acid (CBGA), its decarboxylated derivative cannabigerol (CBG) and the Δ9-THC oxidation product cannabinol (CBN) were also detected with the latter being the least abundant of all phytocannabinoids [18]. The profiling of phytocannabinoids in the juvenile stages of C. sativa was recently described by Fulvio et al. (2023), highlighting the capacity of different genotypes to produce and accumulate phytocannabinoids, predominantly cannabichromenic acid (CBCA), at very early vegetative growth stages, as previously reported [19].
All these findings support the idea of hemp sprouts as a functional food described by the presence of all essential amino acids, lower amount of oxalate compared to other sprouts species and the remarkable content of cannflavins A and B [18]. Additionally, the consumption of hemp sprouts was reported to be widely safe in terms of the amount of the narcotic tetrahydrocannabinol (THC), which was far below the USA and EU limit of 0.3% [18]. The latter refers to the total THC limit in the plant and not in the finished product, which has been so far established, at least in Italy, only for some type of hemp food products including hemp seed oil (THC limit 5 ppm), hemp seeds and hemp flour, as well as supplements derived from hemp (THC limit 2 ppm) [20]. A more recent regulation was issued by the European Commission on the maximum values of THC in food, imposing limits of 3 ppm in hemp seeds and hemp flour and 7.5 ppm in hemp seed oil [21]. Total THC is to be intended as the sum of the carboxylated (THCA) and decarboxylated (Δ9-THC and Δ8-THC) species. However, the thresholds have not been updated for other types of hemp derived products or other phytocannabinoids.
As the literature is still scarce on this matter, the present work aims to provide a detailed overview of all phytocannabinoids present in hemp seeds, sprouts, and microgreens, with a particular focus on the differences between the various tissues of the hemp sprouts. Unlike their mature counterparts, there is no specific time of the year for the sprouts and microgreens growth and the only requirement for their production is the availability of good certified seeds with high germinability. Also, they require minimum space and no special care so they are also suitable for domestic cultivation. As an additional advantage, they contain a higher level of beneficial phytonutrients compared to the mature material that are all preserved as long as they are consumed raw [22]. As the hemp-based food market is growing, there is the need to shed light on the chemical composition of these products and, in particular on their phytocannabinoids profile.
A recently developed untargeted metabolomics approach called phytocannabinomics [9] was employed for the qualitative and semi-quantitative analysis of the different phytocannabinoid species accompanied by a multivariate statistical analysis. At the same time, a targeted analysis of the major phytocannabinoids including CBDA, CBD, THCA, trans-Δ9-THC, CBGA, CBG, cannabichromenic acid (CBCA) and cannabichromene (CBC) was carried out for quantitative purposes. The determination of phytocannabinoids levels in hemp products is particularly important as these compounds are known to exert several beneficial health effects and can add value to this new “functional food”. Both qualitative and quantitative analyses were carried out by high performance liquid chromatography coupled to high-resolution Orbitrap mass spectrometry (HPLC-HRMS). The analysis of CBC-type phytocannabinoids is particularly important as this species are produced in higher levels in the early stages of plant growth to decrease at maturation. Moreover, considering the recent interest in their pharmacological activity, the evaluation of the enantiomeric composition of CBCA in these hemp products was carried out by HPLC-UV to shed some light on its stereochemical behavior at these early growth stages.
Access through your organization
Check access to the full text by signing in through your organization.
Section snippets
Chemicals and reagents
LC-MS grade acetonitrile and formic acid and analytical grade ethanol 96% (v/v) were purchased from Honeywell (Charlotte, North Caroline, USA). A water purification system (Direct-Q 3UV, Merck Millipore, Milan, Italy) was used to make ultrapure water for HPLC-HRMS analyses. Stock solutions of pure certified analytical standards of cannabigerovarinic acid (CBGVA), cannabidivarinic acid (CBDVA), tetrahydrocannabivarinic acid (THCVA), cannabichromevarinic acid (CBCVA), cannabigerolic acid (CBGA),
Phytocannabinomics of hemp food products
Metabolomics is undoubtedly a powerful tool for the chemical profiling of hemp food products as it allows to provide a comprehensive overview of all the metabolites present in a specific sample. In particular, phytocannabinomics proved to be a valuable approach for the characterization of the whole set of phytocannabinoid compounds in cannabis samples [9]. The application of such an approach to hemp food products including seeds, sprouts, and microgreens disclosed a plethora of
Conclusions
Hemp sprouts and hemp-based food products are emerging as a new class of functional food due to their high content of essential amino acids and numerous health benefits when compared to other sprout species. Additionally, they are considered safe for consumption in terms of the amount of the narcotic component THC. However, the available literature on this topic is limited and often conflicting. In this study, we provide a comprehensive overview of all the phytocannabinoids found in hemp seeds,
Funding
This work was funded by UNIHEMP research project “Use of iNdustrIal Hemp biomass for Energy and new biocheMicals Production” (ARS01_00668) funded by Fondo Europeo di Sviluppo Regionale (FESR) (within the PON R&I 2017–2020 – Axis 2 – Action II – OS 1.b). Grant decree UNIHEMP prot. n. 2016 of 27/07/2018; CUP B76C18000520005.
The work was also supported by the Italian Ministry of Research, under the complementary actions to the NRRP “Fit4MedRob – Fit for Medical Robotics” Grant (# PNC0000007).
CRediT authorship contribution statement
Fabiana Russo: Formal analysis, Validation, Writing – review & editing. Elena Ferri: Formal analysis, Methodology, Writing – review & editing, Investigation. Roberta Paris: Resources, Writing – review & editing. Maria Angela Vandelli: Data curation, Validation, Writing – review & editing. Anna Laura Capriotti: Data curation, Validation, Writing – review & editing. Aldo Laganà: Data curation, Validation, Writing – review & editing. Augusto Siciliano: Formal analysis, Validation, Writing – review
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgements
The authors wish to thank Dr. Elisabetta Perrone of the CNR NANOTEC (Lecce) for her technical support and Dr. Massimo Montanari of the CREA-CI (Bologna) for providing the seeds of hemp accessions. The authors also acknowledge Dr. Diego Pinetti for his technical support and the “Fondazione Cassa di Risparmio di Modena” for funding the UHPLC-QExactive system at the Centro Interdipartimentale Grandi Strumenti (CIGS) of the University of Modena and Reggio Emilia.
References (40)
- et al.
Phytocannabinoids: a unified critical inventory
Nat. Prod. Rep.
(2016) - et al.
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog
J. Pharm. Biomed. Anal.
(2019) - et al.
Cis-Δ9-tetrahydrocannabinolic acid occurrence in Cannabis sativa L
J. Pharm. Biomed. Anal.
(2022) - et al.
Phytocannabinomics: untargeted metabolomics as a tool for cannabis chemovar differentiation
Talanta
(2021) - et al.
Cannabinoids vs. whole metabolome: Relevance of cannabinomics in analyzing Cannabis varieties
Anal. Chim. Acta
(2021) - et al.
Cannflavins from hemp sprouts, a novel cannabinoid-free hemp food product, target microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase
PharmaNutrition
(2014) - et al.
Nutraceutical potential of hemp (Cannabis sativa L.) seeds and sprouts
Food Chem.
(2018) - et al.
Isolation from Cannabis sativa L. of cannflavin—a novel inhibitor of prostaglandin production
Biochem. Pharmacol.
(1985) - et al.
Pascale, Hemp microgreens as an innovative functional food: Variation in the organic acids, amino acids, polyphenols, and cannabinoids composition of six hemp cultivars
Food Res. Int.
(2022) - et al.
Phytocannabinoids biosynthesis during early stages of development of young Cannabis sativa L. seedlings: Integrating biochemical and transcription data
Phytochemistry
(2023) - et al.
Bidimensional heart-cut achiral-chiral liquid chromatography coupled to high-resolution mass spectrometry for the separation of the main chiral phytocannabinoids and enantiomerization studies of cannabichromene and cannabichromenic acid
Talanta
(2024) - et al.
Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways
Int. Immunopharmacol.
(2006) - et al.
The current status of artisanal cannabis for the treatment of epilepsy in the United States
Epilepsy Behav.
(2017) - et al.
Enantioseparation of chiral phytocannabinoids in medicinal cannabis
J. Chromatogr. B
(2023) - et al.
Cannabichromene racemization and absolute stereochemistry based on a cannabicyclol analog
J. Org. Chem.
(2021) - et al.
A review of hemp as food and nutritional supplement
Cannabis Cannabinoid Res.
(2021) - et al.
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol
Sci. Rep.
(2019) - et al.
Isolation of a high-affinity cannabinoid for the human CB1 receptor from a medicinal Cannabis sativa variety: Δ9-Tetrahydrocannabutol, the butyl homologue of Δ9-Tetrahydrocannabinol
J. Nat. Prod.
(2020) - et al.
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol
Sci. Rep.
(2020) - et al.
Δ9-cis-Tetrahydrocannabinol: natural occurrence, chirality, and pharmacology
J. Nat. Prod.
(2021)